Finding participants for clinical trials is frequently more challenging than conducting the trials themselves. A delay in recruitment extends the study's timeline, delaying the treatment's market availability. Take a look at the infographic below to comprehend how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.
Patient Recruitment and Enrollment Infographic
Discovering Clinical Trials
Seventy-two percent of participants are existing patients, while 28% are new.
Top sources of clinical trial information:
58% from primary care physicians
40% from online registries
Thirty percent from search engines
Nineteen percent from primary care nurses
Nineteen percent from pharmaceutical companies
Motivations for Participation
Top perceived benefits:
26% to advance medicine
36% to improve others' lives
15% to improve their condition
Eight percent as the best treatment option
Five percent for monetary compensation
Factors influencing participation:
Sixty percent physical location
Sixty-three percent confidentiality
Seventy-three percent types of procedures
75% study purpose
83% potential risks and benefits
Enrollment Challenges
Thirty-seven percent of sites under-enroll, with eleven percent failing to enroll any patients.
Doubling original timelines helps 90% of trials meet enrollment goals.
70% of the public haven't considered clinical trials, with nineteen percent unwilling to participate and 7% unsure.
Top perceived risks:
40% side effects
33% overall health risks
Seven percent receiving placebo
Seven percent stopping beneficial treatments
40% lack confidence in finding a suitable study, here and seventy percent seldom consider clinical trials when discussing treatment options.
However, there's optimism for improvement: Seventy-four percent are open to discussing trial participation in online peer communities, and 94% of volunteers would participate again.
To learn more visit our website at https://recruitqualified.com
Patient Recruitment and Enrollment in Clinical Trials